Cargando…

Precision medicine in type 1 diabetes

First envisioned by early diabetes clinicians, a person-centred approach to care was an aspirational goal that aimed to match insulin therapy to each individual’s unique requirements. In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Alice L. J., Evans-Molina, Carmella, Oram, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522741/
https://www.ncbi.nlm.nih.gov/pubmed/35994083
http://dx.doi.org/10.1007/s00125-022-05778-3
_version_ 1784800123289600000
author Carr, Alice L. J.
Evans-Molina, Carmella
Oram, Richard A.
author_facet Carr, Alice L. J.
Evans-Molina, Carmella
Oram, Richard A.
author_sort Carr, Alice L. J.
collection PubMed
description First envisioned by early diabetes clinicians, a person-centred approach to care was an aspirational goal that aimed to match insulin therapy to each individual’s unique requirements. In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1 diabetes diagnosis, treatment, prevention and prediction. These advances have been facilitated by the recognition of type 1 diabetes as an autoimmune disease and by advances in our understanding of diabetes pathophysiology, genetics and natural history, which have occurred in parallel with advancements in insulin delivery, glucose monitoring and tools for self-management. In this review, we discuss how these personalised approaches have improved diabetes care and how improved understanding of pathogenesis and human biology might inform precision medicine in the future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a slideset of the figures for download available at 10.1007/s00125-022-05778-3.
format Online
Article
Text
id pubmed-9522741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95227412022-10-01 Precision medicine in type 1 diabetes Carr, Alice L. J. Evans-Molina, Carmella Oram, Richard A. Diabetologia Review First envisioned by early diabetes clinicians, a person-centred approach to care was an aspirational goal that aimed to match insulin therapy to each individual’s unique requirements. In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1 diabetes diagnosis, treatment, prevention and prediction. These advances have been facilitated by the recognition of type 1 diabetes as an autoimmune disease and by advances in our understanding of diabetes pathophysiology, genetics and natural history, which have occurred in parallel with advancements in insulin delivery, glucose monitoring and tools for self-management. In this review, we discuss how these personalised approaches have improved diabetes care and how improved understanding of pathogenesis and human biology might inform precision medicine in the future. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains a slideset of the figures for download available at 10.1007/s00125-022-05778-3. Springer Berlin Heidelberg 2022-08-22 2022 /pmc/articles/PMC9522741/ /pubmed/35994083 http://dx.doi.org/10.1007/s00125-022-05778-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Carr, Alice L. J.
Evans-Molina, Carmella
Oram, Richard A.
Precision medicine in type 1 diabetes
title Precision medicine in type 1 diabetes
title_full Precision medicine in type 1 diabetes
title_fullStr Precision medicine in type 1 diabetes
title_full_unstemmed Precision medicine in type 1 diabetes
title_short Precision medicine in type 1 diabetes
title_sort precision medicine in type 1 diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522741/
https://www.ncbi.nlm.nih.gov/pubmed/35994083
http://dx.doi.org/10.1007/s00125-022-05778-3
work_keys_str_mv AT carralicelj precisionmedicineintype1diabetes
AT evansmolinacarmella precisionmedicineintype1diabetes
AT oramricharda precisionmedicineintype1diabetes